| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammasomes | 18 | 2023 | 334 | 2.900 |
Why?
|
| Caspase 8 | 8 | 2025 | 65 | 2.850 |
Why?
|
| Inflammation | 16 | 2025 | 1147 | 2.000 |
Why?
|
| Immunity, Innate | 11 | 2020 | 795 | 1.970 |
Why?
|
| Plague | 7 | 2018 | 23 | 1.960 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 4 | 2025 | 81 | 1.620 |
Why?
|
| Yersinia pestis | 8 | 2016 | 33 | 1.580 |
Why?
|
| Toll-Like Receptor 4 | 21 | 2023 | 344 | 1.540 |
Why?
|
| Cell Death | 7 | 2025 | 284 | 1.530 |
Why?
|
| Adjuvants, Immunologic | 8 | 2015 | 227 | 1.340 |
Why?
|
| Signal Transduction | 37 | 2025 | 3035 | 1.300 |
Why?
|
| Macrophages | 15 | 2025 | 1039 | 1.270 |
Why?
|
| Pyroptosis | 3 | 2025 | 32 | 1.260 |
Why?
|
| Receptors, Cell Surface | 20 | 2005 | 429 | 1.220 |
Why?
|
| Membrane Glycoproteins | 19 | 2005 | 669 | 1.150 |
Why?
|
| Carrier Proteins | 8 | 2018 | 707 | 1.100 |
Why?
|
| Interleukin-1beta | 12 | 2023 | 265 | 1.070 |
Why?
|
| Animals | 78 | 2025 | 20660 | 1.020 |
Why?
|
| Mice | 60 | 2025 | 10844 | 1.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 12 | 2014 | 204 | 0.980 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2016 | 121 | 0.950 |
Why?
|
| Mice, Knockout | 27 | 2025 | 2109 | 0.930 |
Why?
|
| Lipid A | 6 | 2015 | 66 | 0.910 |
Why?
|
| Interleukin-18 | 9 | 2020 | 74 | 0.890 |
Why?
|
| Toll-Like Receptor 2 | 16 | 2014 | 222 | 0.880 |
Why?
|
| Toll-Like Receptors | 25 | 2020 | 431 | 0.880 |
Why?
|
| Lipopolysaccharides | 19 | 2020 | 624 | 0.840 |
Why?
|
| Yersinia Infections | 3 | 2025 | 10 | 0.840 |
Why?
|
| RNA Splicing | 1 | 2025 | 162 | 0.840 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 14 | 2023 | 258 | 0.830 |
Why?
|
| Mice, Inbred C57BL | 28 | 2025 | 3396 | 0.770 |
Why?
|
| Apoptosis Regulatory Proteins | 6 | 2018 | 149 | 0.770 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2019 | 337 | 0.750 |
Why?
|
| RNA-Binding Proteins | 2 | 2025 | 435 | 0.750 |
Why?
|
| Host-Pathogen Interactions | 3 | 2018 | 262 | 0.720 |
Why?
|
| Saponins | 3 | 2015 | 29 | 0.690 |
Why?
|
| Dendritic Cells | 10 | 2020 | 525 | 0.690 |
Why?
|
| AIDS Vaccines | 3 | 2015 | 71 | 0.640 |
Why?
|
| Protein Kinases | 2 | 2023 | 152 | 0.600 |
Why?
|
| Sugars | 1 | 2018 | 5 | 0.600 |
Why?
|
| Bacterial Proteins | 5 | 2019 | 768 | 0.590 |
Why?
|
| I-kappa B Kinase | 1 | 2018 | 50 | 0.590 |
Why?
|
| Lipopolysaccharide Receptors | 11 | 2020 | 144 | 0.580 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2018 | 36 | 0.580 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2018 | 82 | 0.570 |
Why?
|
| Virulence | 3 | 2016 | 193 | 0.550 |
Why?
|
| Bacterial Infections | 2 | 2023 | 149 | 0.540 |
Why?
|
| Pyrin | 1 | 2016 | 7 | 0.520 |
Why?
|
| Bacterial Secretion Systems | 1 | 2016 | 10 | 0.520 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 3 | 2014 | 81 | 0.520 |
Why?
|
| Cells, Cultured | 16 | 2019 | 2157 | 0.470 |
Why?
|
| Receptors, Interleukin | 1 | 2014 | 38 | 0.450 |
Why?
|
| Lymphocyte Antigen 96 | 6 | 2009 | 47 | 0.440 |
Why?
|
| Cytokines | 12 | 2023 | 935 | 0.430 |
Why?
|
| Drosophila Proteins | 10 | 2003 | 688 | 0.410 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2013 | 16 | 0.410 |
Why?
|
| Docosahexaenoic Acids | 1 | 2013 | 31 | 0.410 |
Why?
|
| Virulence Factors | 2 | 2019 | 84 | 0.390 |
Why?
|
| NF-kappa B | 8 | 2018 | 469 | 0.350 |
Why?
|
| Macrophages, Peritoneal | 6 | 2014 | 77 | 0.310 |
Why?
|
| Receptors, Immunologic | 5 | 2016 | 177 | 0.310 |
Why?
|
| Phosphate-Binding Proteins | 2 | 2019 | 19 | 0.300 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2018 | 199 | 0.300 |
Why?
|
| Apoptosis | 6 | 2023 | 1079 | 0.300 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 1617 | 0.300 |
Why?
|
| RNA, Double-Stranded | 3 | 2011 | 112 | 0.290 |
Why?
|
| Antigens, Differentiation | 4 | 2004 | 138 | 0.290 |
Why?
|
| Streptococcus agalactiae | 4 | 2014 | 79 | 0.290 |
Why?
|
| Humans | 51 | 2024 | 63446 | 0.280 |
Why?
|
| Toll-Like Receptor 3 | 4 | 2013 | 66 | 0.270 |
Why?
|
| Plague Vaccine | 1 | 2006 | 5 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2009 | 621 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 697 | 0.250 |
Why?
|
| Up-Regulation | 7 | 2015 | 374 | 0.250 |
Why?
|
| Caspase 1 | 6 | 2023 | 111 | 0.240 |
Why?
|
| Bone Marrow Cells | 3 | 2015 | 238 | 0.230 |
Why?
|
| Disease Resistance | 1 | 2025 | 24 | 0.230 |
Why?
|
| Vaccines, DNA | 3 | 2014 | 98 | 0.230 |
Why?
|
| HIV Envelope Protein gp120 | 3 | 2015 | 133 | 0.230 |
Why?
|
| Interferon-beta | 3 | 2014 | 80 | 0.220 |
Why?
|
| Gram-Negative Bacteria | 2 | 2018 | 57 | 0.220 |
Why?
|
| Interferons | 1 | 2024 | 73 | 0.210 |
Why?
|
| Microglia | 3 | 2021 | 242 | 0.210 |
Why?
|
| Disease Models, Animal | 7 | 2021 | 2187 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2016 | 394 | 0.200 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2010 | 126 | 0.200 |
Why?
|
| Immunoglobulin G | 2 | 2015 | 459 | 0.200 |
Why?
|
| Epithelial Cells | 2 | 2024 | 390 | 0.200 |
Why?
|
| Hepatitis | 1 | 2023 | 57 | 0.200 |
Why?
|
| Islets of Langerhans | 2 | 2018 | 279 | 0.190 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 242 | 0.190 |
Why?
|
| Models, Biological | 4 | 2016 | 1180 | 0.180 |
Why?
|
| Cell Line | 13 | 2010 | 2040 | 0.180 |
Why?
|
| Toll-Like Receptor 9 | 6 | 2013 | 211 | 0.180 |
Why?
|
| Schiff Bases | 1 | 2001 | 1 | 0.180 |
Why?
|
| Semicarbazides | 1 | 2001 | 2 | 0.180 |
Why?
|
| Ventricular Remodeling | 2 | 2020 | 83 | 0.180 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2023 | 77 | 0.180 |
Why?
|
| Influenza A virus | 1 | 2023 | 123 | 0.180 |
Why?
|
| Lysosomes | 5 | 2014 | 166 | 0.180 |
Why?
|
| T-Lymphocytes | 5 | 2014 | 1007 | 0.180 |
Why?
|
| Endosomes | 3 | 2014 | 177 | 0.180 |
Why?
|
| Th1 Cells | 3 | 2015 | 173 | 0.170 |
Why?
|
| Cholesterol | 2 | 2014 | 259 | 0.170 |
Why?
|
| Interferon-gamma | 6 | 2020 | 567 | 0.170 |
Why?
|
| Proteolysis | 2 | 2019 | 145 | 0.170 |
Why?
|
| Myocardium | 2 | 2020 | 279 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 6 | 2023 | 429 | 0.170 |
Why?
|
| Th2 Cells | 2 | 2015 | 98 | 0.170 |
Why?
|
| Malaria, Cerebral | 1 | 2020 | 22 | 0.170 |
Why?
|
| Complement C3 | 2 | 2020 | 59 | 0.170 |
Why?
|
| Interferon Regulatory Factor-3 | 4 | 2014 | 97 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2023 | 208 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 149 | 0.160 |
Why?
|
| Acyltransferases | 3 | 2009 | 31 | 0.160 |
Why?
|
| Angiotensin II | 1 | 2020 | 25 | 0.160 |
Why?
|
| Inflammation Mediators | 3 | 2010 | 177 | 0.160 |
Why?
|
| Macrophage Activation | 5 | 2018 | 119 | 0.160 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 90 | 0.150 |
Why?
|
| Streptolysins | 1 | 2019 | 10 | 0.150 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 31 | 0.150 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2020 | 87 | 0.150 |
Why?
|
| Type III Secretion Systems | 1 | 2018 | 4 | 0.150 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 80 | 0.150 |
Why?
|
| Immunity | 1 | 2019 | 107 | 0.150 |
Why?
|
| Multiple Sclerosis | 1 | 2021 | 218 | 0.140 |
Why?
|
| CARD Signaling Adaptor Proteins | 5 | 2023 | 67 | 0.140 |
Why?
|
| Endocytosis | 3 | 2014 | 152 | 0.140 |
Why?
|
| Sepsis | 1 | 2002 | 289 | 0.140 |
Why?
|
| Monocytes | 6 | 2020 | 353 | 0.140 |
Why?
|
| Pneumonia, Bacterial | 2 | 2016 | 89 | 0.140 |
Why?
|
| Escherichia coli Proteins | 3 | 2009 | 271 | 0.130 |
Why?
|
| Palmitates | 1 | 2016 | 21 | 0.130 |
Why?
|
| Interleukin-6 | 7 | 2020 | 321 | 0.130 |
Why?
|
| Disease | 1 | 2016 | 27 | 0.130 |
Why?
|
| Astrocytes | 2 | 2015 | 119 | 0.130 |
Why?
|
| HIV Antibodies | 2 | 2014 | 146 | 0.130 |
Why?
|
| Phagocytosis | 3 | 2010 | 264 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2018 | 298 | 0.130 |
Why?
|
| Bacteria | 2 | 2016 | 306 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2010 | 319 | 0.130 |
Why?
|
| Klebsiella Infections | 1 | 2016 | 22 | 0.120 |
Why?
|
| Klebsiella pneumoniae | 1 | 2016 | 28 | 0.120 |
Why?
|
| Parvovirus | 2 | 2007 | 24 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 663 | 0.120 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cellular Senescence | 1 | 2016 | 110 | 0.120 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2015 | 9 | 0.120 |
Why?
|
| GTP-Binding Proteins | 1 | 2015 | 84 | 0.120 |
Why?
|
| Solubility | 1 | 2015 | 180 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 207 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 3 | 2013 | 200 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2014 | 622 | 0.120 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2014 | 5 | 0.110 |
Why?
|
| Chemokine CCL4 | 1 | 2014 | 14 | 0.110 |
Why?
|
| RNA, Messenger | 7 | 2020 | 1537 | 0.110 |
Why?
|
| Chemokine CCL5 | 1 | 2014 | 33 | 0.110 |
Why?
|
| Viral Envelope Proteins | 1 | 2015 | 103 | 0.110 |
Why?
|
| Mice, Inbred C3H | 5 | 2010 | 176 | 0.110 |
Why?
|
| Rats | 5 | 2013 | 1980 | 0.110 |
Why?
|
| Aluminum Hydroxide | 1 | 2014 | 3 | 0.110 |
Why?
|
| Heart | 1 | 2016 | 283 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 9 | 2011 | 615 | 0.110 |
Why?
|
| Phagosomes | 2 | 2014 | 54 | 0.110 |
Why?
|
| Immunization, Secondary | 1 | 2014 | 48 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 95 | 0.110 |
Why?
|
| Cell Survival | 1 | 2015 | 575 | 0.110 |
Why?
|
| RNA, Bacterial | 1 | 2014 | 74 | 0.100 |
Why?
|
| Hemolysin Proteins | 1 | 2014 | 44 | 0.100 |
Why?
|
| Phospholipids | 1 | 2014 | 82 | 0.100 |
Why?
|
| Male | 18 | 2024 | 29889 | 0.100 |
Why?
|
| Immunization | 1 | 2014 | 133 | 0.100 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2013 | 28 | 0.100 |
Why?
|
| Borrelia | 2 | 2010 | 32 | 0.100 |
Why?
|
| rab GTP-Binding Proteins | 2 | 2010 | 79 | 0.100 |
Why?
|
| Toll-Like Receptor 5 | 2 | 2003 | 11 | 0.100 |
Why?
|
| Intestines | 1 | 2013 | 165 | 0.100 |
Why?
|
| Ligands | 2 | 2004 | 416 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 147 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2014 | 288 | 0.090 |
Why?
|
| HIV-1 | 2 | 2014 | 721 | 0.090 |
Why?
|
| Neisseria gonorrhoeae | 2 | 2005 | 200 | 0.090 |
Why?
|
| Interleukin-12 Subunit p40 | 2 | 2008 | 17 | 0.090 |
Why?
|
| Lung | 3 | 2015 | 956 | 0.090 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 189 | 0.090 |
Why?
|
| Brain | 2 | 2020 | 1552 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2013 | 261 | 0.090 |
Why?
|
| Obesity | 1 | 2019 | 1235 | 0.090 |
Why?
|
| RNA Stability | 1 | 2011 | 102 | 0.090 |
Why?
|
| Flow Cytometry | 4 | 2010 | 664 | 0.090 |
Why?
|
| Shock, Septic | 2 | 2010 | 86 | 0.090 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2010 | 10 | 0.090 |
Why?
|
| Toxoplasmosis, Animal | 1 | 2010 | 10 | 0.080 |
Why?
|
| CpG Islands | 3 | 2010 | 216 | 0.080 |
Why?
|
| Relapsing Fever | 1 | 2010 | 17 | 0.080 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 37 | 0.080 |
Why?
|
| Tamoxifen | 1 | 2010 | 41 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2010 | 35 | 0.080 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2010 | 21 | 0.080 |
Why?
|
| Antibody Formation | 1 | 2010 | 114 | 0.080 |
Why?
|
| Lymphocyte Activation | 2 | 2010 | 758 | 0.080 |
Why?
|
| Antibodies, Bacterial | 2 | 2010 | 181 | 0.080 |
Why?
|
| Female | 16 | 2024 | 32878 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 45 | 0.080 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 128 | 0.080 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 135 | 0.080 |
Why?
|
| Chlamydia Infections | 1 | 2010 | 75 | 0.080 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2009 | 15 | 0.080 |
Why?
|
| Cell Membrane | 4 | 2008 | 496 | 0.080 |
Why?
|
| Enzyme Activation | 3 | 2020 | 381 | 0.080 |
Why?
|
| Boutonneuse Fever | 1 | 2008 | 1 | 0.080 |
Why?
|
| Rickettsia Infections | 1 | 2008 | 1 | 0.080 |
Why?
|
| Insect Bites and Stings | 1 | 2008 | 2 | 0.080 |
Why?
|
| Rats, Inbred BB | 1 | 2009 | 134 | 0.080 |
Why?
|
| Diet, High-Fat | 2 | 2020 | 175 | 0.070 |
Why?
|
| Bacterial Vaccines | 1 | 2009 | 78 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 540 | 0.070 |
Why?
|
| In Vitro Techniques | 4 | 2020 | 490 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2010 | 153 | 0.070 |
Why?
|
| Liver | 3 | 2020 | 855 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2008 | 92 | 0.070 |
Why?
|
| Teichoic Acids | 1 | 2008 | 13 | 0.070 |
Why?
|
| Chemokines | 1 | 2008 | 93 | 0.070 |
Why?
|
| CD36 Antigens | 1 | 2008 | 26 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2014 | 883 | 0.070 |
Why?
|
| Trypanosoma cruzi | 1 | 2008 | 52 | 0.070 |
Why?
|
| Neutrophils | 2 | 2016 | 377 | 0.070 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 525 | 0.070 |
Why?
|
| HIV Infections | 2 | 2004 | 969 | 0.070 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2007 | 34 | 0.070 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2008 | 164 | 0.070 |
Why?
|
| B-Lymphocytes | 2 | 2007 | 572 | 0.070 |
Why?
|
| Immunoglobulin M | 1 | 2007 | 115 | 0.070 |
Why?
|
| CHO Cells | 3 | 2002 | 189 | 0.070 |
Why?
|
| Health | 1 | 2007 | 31 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 2 | 2008 | 173 | 0.070 |
Why?
|
| Spleen | 3 | 2020 | 483 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2009 | 212 | 0.060 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2008 | 245 | 0.060 |
Why?
|
| Rhinovirus | 1 | 2006 | 4 | 0.060 |
Why?
|
| Poly I-C | 3 | 2013 | 76 | 0.060 |
Why?
|
| Cricetinae | 3 | 2002 | 367 | 0.060 |
Why?
|
| Cell Movement | 1 | 2008 | 453 | 0.060 |
Why?
|
| Antigens, Bacterial | 1 | 2007 | 199 | 0.060 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 916 | 0.060 |
Why?
|
| Complement C4b-Binding Protein | 1 | 2005 | 28 | 0.060 |
Why?
|
| Golgi Apparatus | 2 | 2003 | 64 | 0.060 |
Why?
|
| Interleukin-1 | 4 | 2010 | 156 | 0.060 |
Why?
|
| Fibrosis | 2 | 2020 | 160 | 0.060 |
Why?
|
| Interleukin-8 | 2 | 2003 | 88 | 0.060 |
Why?
|
| Parvoviridae Infections | 1 | 2005 | 23 | 0.060 |
Why?
|
| Antigens, Surface | 2 | 2002 | 197 | 0.060 |
Why?
|
| Interleukin-10 | 3 | 2015 | 160 | 0.060 |
Why?
|
| Cell Wall | 2 | 2003 | 118 | 0.060 |
Why?
|
| Bacteroidaceae Infections | 1 | 2004 | 3 | 0.060 |
Why?
|
| Porphyromonas gingivalis | 1 | 2004 | 17 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 32 | 0.050 |
Why?
|
| Dimerization | 3 | 2009 | 145 | 0.050 |
Why?
|
| Periodontitis | 1 | 2004 | 15 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2006 | 143 | 0.050 |
Why?
|
| Regeneration | 1 | 2024 | 95 | 0.050 |
Why?
|
| Signaling Lymphocytic Activation Molecule Family | 1 | 2023 | 6 | 0.050 |
Why?
|
| Vaccination | 1 | 2006 | 362 | 0.050 |
Why?
|
| Colitis | 1 | 2024 | 77 | 0.050 |
Why?
|
| Gonorrhea | 1 | 2005 | 158 | 0.050 |
Why?
|
| Organ Size | 2 | 2020 | 170 | 0.050 |
Why?
|
| Neutrophil Activation | 1 | 2023 | 24 | 0.050 |
Why?
|
| Transfection | 5 | 2003 | 694 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2024 | 102 | 0.050 |
Why?
|
| Burns | 1 | 2003 | 41 | 0.050 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2003 | 24 | 0.050 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 1186 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 864 | 0.050 |
Why?
|
| Measles virus | 1 | 2002 | 2 | 0.050 |
Why?
|
| Escherichia coli | 4 | 2010 | 707 | 0.050 |
Why?
|
| Hemagglutinins, Viral | 1 | 2002 | 12 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 454 | 0.050 |
Why?
|
| Hexuronic Acids | 1 | 2002 | 22 | 0.050 |
Why?
|
| Gene Expression | 2 | 2016 | 840 | 0.050 |
Why?
|
| Immune System | 1 | 2003 | 130 | 0.050 |
Why?
|
| Cushing Syndrome | 1 | 2002 | 6 | 0.050 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2002 | 57 | 0.050 |
Why?
|
| Disease Susceptibility | 2 | 2016 | 165 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2002 | 197 | 0.050 |
Why?
|
| Cervix Uteri | 1 | 2002 | 60 | 0.050 |
Why?
|
| Vagina | 1 | 2002 | 83 | 0.050 |
Why?
|
| Growth Inhibitors | 1 | 2001 | 26 | 0.050 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2002 | 49 | 0.050 |
Why?
|
| Protein Binding | 3 | 2015 | 1603 | 0.050 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2001 | 83 | 0.050 |
Why?
|
| Biopolymers | 1 | 2002 | 71 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 93 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2001 | 110 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1198 | 0.040 |
Why?
|
| Mammals | 1 | 2003 | 218 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2002 | 224 | 0.040 |
Why?
|
| Biomarkers | 3 | 2020 | 1408 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 78 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 191 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2002 | 139 | 0.040 |
Why?
|
| Microscopy, Confocal | 3 | 2010 | 235 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 456 | 0.040 |
Why?
|
| Disease Progression | 2 | 2021 | 1172 | 0.040 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2020 | 12 | 0.040 |
Why?
|
| Plasmodium chabaudi | 1 | 2020 | 29 | 0.040 |
Why?
|
| Benzoquinones | 1 | 2020 | 14 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2020 | 19 | 0.040 |
Why?
|
| Lactams, Macrocyclic | 1 | 2020 | 25 | 0.040 |
Why?
|
| Cell Division | 1 | 2001 | 450 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2020 | 30 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2020 | 34 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2002 | 298 | 0.040 |
Why?
|
| Peptides | 1 | 2023 | 574 | 0.040 |
Why?
|
| Ethanol | 1 | 2023 | 321 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 864 | 0.040 |
Why?
|
| Drosophila | 1 | 2003 | 433 | 0.040 |
Why?
|
| Systole | 1 | 2020 | 108 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2020 | 139 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2020 | 99 | 0.040 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2020 | 65 | 0.040 |
Why?
|
| Neisseria meningitidis | 1 | 2000 | 78 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2020 | 218 | 0.040 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 128 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2019 | 111 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 281 | 0.040 |
Why?
|
| src-Family Kinases | 2 | 2010 | 64 | 0.040 |
Why?
|
| Middle Aged | 6 | 2020 | 17615 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2002 | 313 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 489 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 230 | 0.030 |
Why?
|
| Time Factors | 3 | 2013 | 3768 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2020 | 512 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 489 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 14 | 0.030 |
Why?
|
| Insulin-Secreting Cells | 1 | 2018 | 189 | 0.030 |
Why?
|
| Cell Separation | 2 | 2010 | 147 | 0.030 |
Why?
|
| Panax | 1 | 1996 | 2 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2011 | 226 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 542 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 2016 | 77 | 0.030 |
Why?
|
| Vaccines, Attenuated | 2 | 2009 | 36 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 302 | 0.030 |
Why?
|
| Plants, Medicinal | 1 | 1996 | 61 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2016 | 80 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 702 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2019 | 412 | 0.030 |
Why?
|
| Base Sequence | 2 | 2011 | 1331 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 1991 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2015 | 7 | 0.030 |
Why?
|
| Insulin | 1 | 2019 | 686 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 42 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 48 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 239 | 0.030 |
Why?
|
| Toll-Like Receptor 1 | 2 | 2007 | 22 | 0.030 |
Why?
|
| Polysaccharides | 1 | 1996 | 144 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2015 | 68 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 673 | 0.030 |
Why?
|
| Leukocytes | 1 | 2015 | 103 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 123 | 0.030 |
Why?
|
| Arteries | 1 | 2015 | 81 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2004 | 94 | 0.030 |
Why?
|
| Species Specificity | 2 | 2005 | 334 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2008 | 242 | 0.030 |
Why?
|
| Vaccines, Subunit | 1 | 2014 | 40 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 165 | 0.030 |
Why?
|
| Adult | 4 | 2020 | 16823 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 378 | 0.030 |
Why?
|
| Rabbits | 1 | 2014 | 333 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 896 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2013 | 88 | 0.020 |
Why?
|
| Potassium | 1 | 2013 | 100 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 185 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2005 | 612 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 209 | 0.020 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2011 | 9 | 0.020 |
Why?
|
| Half-Life | 1 | 2011 | 80 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2011 | 94 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 293 | 0.020 |
Why?
|
| CD18 Antigens | 2 | 2002 | 30 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 268 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 2003 | 367 | 0.020 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2010 | 26 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2010 | 7 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 31 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2010 | 69 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2010 | 22 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2010 | 14 | 0.020 |
Why?
|
| Toxoplasma | 1 | 2010 | 33 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 2010 | 34 | 0.020 |
Why?
|
| Receptor, ErbB-2 | 1 | 2010 | 56 | 0.020 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 204 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2010 | 39 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 41 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 234 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2010 | 128 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 30 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 110 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2010 | 93 | 0.020 |
Why?
|
| Phagocytes | 1 | 2010 | 52 | 0.020 |
Why?
|
| Crystallization | 1 | 2010 | 99 | 0.020 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 43 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 187 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 4694 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 139 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 87 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2010 | 64 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 178 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 126 | 0.020 |
Why?
|
| Leukosialin | 1 | 2009 | 2 | 0.020 |
Why?
|
| Administration, Intranasal | 1 | 2009 | 27 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 278 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2009 | 35 | 0.020 |
Why?
|
| Bacteremia | 1 | 2010 | 94 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2010 | 67 | 0.020 |
Why?
|
| Colony Count, Microbial | 1 | 2009 | 59 | 0.020 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2009 | 5 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 176 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 248 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2010 | 422 | 0.020 |
Why?
|
| Transcription Factor AP-1 | 1 | 2009 | 41 | 0.020 |
Why?
|
| Rickettsieae | 1 | 2008 | 1 | 0.020 |
Why?
|
| Siphonaptera | 1 | 2008 | 1 | 0.020 |
Why?
|
| Chemokine CCL19 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Neoplasms | 1 | 2019 | 1364 | 0.020 |
Why?
|
| Insect Vectors | 1 | 2008 | 15 | 0.020 |
Why?
|
| Ticks | 1 | 2008 | 35 | 0.020 |
Why?
|
| Dynamin I | 1 | 2008 | 1 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2010 | 739 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 120 | 0.020 |
Why?
|
| trans-Golgi Network | 1 | 2008 | 8 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2010 | 730 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 345 | 0.020 |
Why?
|
| Retroelements | 1 | 2008 | 44 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2008 | 36 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2008 | 58 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2008 | 130 | 0.020 |
Why?
|
| Opsonin Proteins | 1 | 2008 | 30 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2009 | 583 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2009 | 247 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 14449 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1094 | 0.020 |
Why?
|
| Biological Transport | 1 | 2008 | 291 | 0.020 |
Why?
|
| Lipids | 1 | 2009 | 315 | 0.020 |
Why?
|
| Borrelia Infections | 1 | 2007 | 12 | 0.020 |
Why?
|
| Breeding | 1 | 2007 | 26 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2007 | 60 | 0.020 |
Why?
|
| Chloroquine | 1 | 2007 | 61 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 507 | 0.020 |
Why?
|
| Dogs | 1 | 2008 | 325 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2006 | 34 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 618 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2006 | 36 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2007 | 136 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2007 | 232 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2005 | 32 | 0.020 |
Why?
|
| Blood Bactericidal Activity | 1 | 2005 | 62 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 1748 | 0.020 |
Why?
|
| Porins | 1 | 2005 | 62 | 0.010 |
Why?
|
| Parvoviridae | 1 | 2005 | 5 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 770 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 2004 | 16 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2005 | 299 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2006 | 536 | 0.010 |
Why?
|
| Vaccinia | 1 | 2005 | 32 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2458 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 618 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 2005 | 64 | 0.010 |
Why?
|
| Interleukins | 1 | 2005 | 80 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2005 | 256 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2005 | 73 | 0.010 |
Why?
|
| Fimbriae, Bacterial | 1 | 2004 | 19 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2004 | 93 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 2004 | 37 | 0.010 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 137 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2004 | 109 | 0.010 |
Why?
|
| Allergens | 1 | 2003 | 53 | 0.010 |
Why?
|
| Antigens, Ly | 1 | 2003 | 42 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 42 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2003 | 277 | 0.010 |
Why?
|
| Brefeldin A | 1 | 2002 | 7 | 0.010 |
Why?
|
| Membrane Cofactor Protein | 1 | 2002 | 1 | 0.010 |
Why?
|
| Measles Vaccine | 1 | 2002 | 2 | 0.010 |
Why?
|
| CD11b Antigen | 1 | 2002 | 19 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 32 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 77 | 0.010 |
Why?
|
| Drug Design | 1 | 2003 | 136 | 0.010 |
Why?
|
| Culture Media | 1 | 2003 | 79 | 0.010 |
Why?
|
| Virus Replication | 1 | 2004 | 321 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2002 | 66 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 109 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1592 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 99 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 2002 | 52 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 257 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 763 | 0.010 |
Why?
|
| Hormones | 1 | 2002 | 60 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 292 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 240 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2002 | 137 | 0.010 |
Why?
|
| Bone Density | 1 | 2002 | 134 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 347 | 0.010 |
Why?
|
| Protein Transport | 1 | 2002 | 402 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2004 | 1119 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2002 | 401 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 200 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2007 | 895 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 1256 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2002 | 193 | 0.010 |
Why?
|
| Neurons | 1 | 2006 | 922 | 0.010 |
Why?
|
| Kidney | 1 | 2003 | 446 | 0.010 |
Why?
|
| CD11 Antigens | 1 | 1999 | 16 | 0.010 |
Why?
|
| Endotoxins | 1 | 1999 | 81 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 2575 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 1996 | 8 | 0.010 |
Why?
|
| Interferon Type I | 1 | 1996 | 187 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 2612 | 0.010 |
Why?
|